September 16, 2024Sick Kids spinout Radiant developing ‘supercharged’ antibody drugs to target HIV, complex cancers
September 13, 2024Revolution, interrupted: Why AI has failed to live up to the hype in drug development
August 22, 2024Ex-Chinook team launches Borealis Biosciences with $150-million from Novartis, Versant
July 12, 2024Ticketmaster’s customer data hack, lie-detecting AI and the rise of super cheap online shopping
March 19, 2024AstraZeneca buys Hamilton-based smart cancer drug maker Fusion Pharmaceuticals for $2-billion
March 13, 2024Two new gene therapies could present possible cure for sickle cell disease, but access is an obstacle
February 14, 2024enGene’s stock skyrockets as Montreal gene therapy developer raises $200-million on Nasdaq
January 19, 2024The Voyage of Sorcerer II traces an expedition to unlock the genetic mysteries of the ocean
December 4, 2023Xenon stock surges as B.C. biotech’s epilepsy drug shows promise for treating depression
November 29, 2023AbCellera cuts 10 per cent of staff as biotech slump hits Vancouver antibody developer
September 6, 2023B.C.-founded biologics developer Tentarix raises US$35-million after securing Gilead deal
July 24, 2023Can a disease-free, drought-proof potato exist? A map of the vegetable’s genes aims to find out
June 12, 2023Novartis buys Chinook for US$3.2-billion, latest in string of big exits for Canadian biotechs
April 20, 2023AbCellera-backed precision medicine startup Abdera raises $140-million to target tumors
April 18, 2023GSK’s $2-billion purchase of Bellus delivers second big exit for Montreal’s Bellini family
